Author:

Patrick McConville, PhD, Senior Vice President/Chief Scientific Officer

Date:

November 17, 2015

With the ability to provide non-invasive, three dimensional, longitudinal, and quantitative data—PET, SPECT, and fluorescence imaging (FMT) enable translational imaging of:

  • Biodistribution
  • Targeting
  • Kinetics
  • Clearance Pathways

In vivo biodistribution imaging applications are now critical assays for biologics characterization for discovery screening, lead candidate selection/optimization and safety. At MI Bioresearch (MI) we combine highly sensitive PET, SPECT, and fluorescence detection with highly specific anatomical characterization using MRI and CT.  The combination of state of the art instruments, software, and disease models at MI are driving rapid, decision enabling studies, using small numbers of animals.

Zr89 Biodistribution Graphic

Talk to one of MI’s scientists about biodistribution imaging for your compound.